These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18418319)

  • 1. Neuromuscular diseases.
    Kelly JJ
    Rev Neurol Dis; 2008; 5(1):23-6. PubMed ID: 18418319
    [No Abstract]   [Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lambert-Eaton myasthenic syndrome with pure ocular weakness.
    Rudnicki SA
    Neurology; 2007 May; 68(21):1863-4. PubMed ID: 17515551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome].
    Boutin E; Rey C; Romeu M; Pouget J; Franques J
    Rev Med Interne; 2013 Aug; 34(8):493-6. PubMed ID: 23759215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-Eaton myasthenic syndrome with prominent postexercise exhaustion.
    Gutmann L; Weidman D; Gutiérrez A
    Muscle Nerve; 1993 Jul; 16(7):716-9. PubMed ID: 8389419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T; Nast CC; Vo A; Jordan SC
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical worsening of anti–myelin-associated glycoprotein polyneuropathy following rituximab.
    Weiss MD; Becker P
    Muscle Nerve; 2014 Mar; 49(3):457-8. PubMed ID: 24741682
    [No Abstract]   [Full Text] [Related]  

  • 11. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is your diagnosis? Lambert-Eaton myasthenic syndrome].
    Kaeser HE
    Schweiz Rundsch Med Prax; 1993 Aug; 82(34):897-8. PubMed ID: 8396791
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
    Wang S; Bruzzi J; Rodriguez-Garza VP; Komaki RR
    Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute respiratory insufficiency as onset form of Lambert-Eaton's syndrome associated with pulmonary small cell carcinoma].
    Jover F; Chiner E; Arriero JM; Signes-Costa J; Marco J; Izura V
    An Med Interna; 2002 May; 19(5):243-5. PubMed ID: 12108000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
    Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
    Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature].
    Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S
    No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review: the use of rituximab in neuromuscular diseases.
    Ibrahim H; Dimachkie MM; Shaibani A
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eaton-Lambert myasthenic syndrome, subacute cortical cerebellar degeneration and somatosensory polyneuropathy in small cell bronchial cancer].
    König F; Rohrmoser B
    Nervenarzt; 1984 Aug; 55(8):436-40. PubMed ID: 6090963
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.
    Morris CS; Esiri MM; Marx A; Newsom-Davis J
    Am J Pathol; 1992 Apr; 140(4):839-45. PubMed ID: 1314026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.